PV Bulletin

Iran Sanctions Legislation Update, 8 September 2026

The UK Government has introduced new sanctions against Iran, focusing on nuclear activities and related industries.

Primary source: Open Government Licence v3.0

PV Impact Brief

Urgency: HighConfidence: high

What changed

The UK Government laid 'The Iran (Sanctions) (Amendment) Regulations 2026', which amend existing sanctions regulations to impose new sectoral measures against Iran, including expanded trade prohibitions and a ban on Iranian aircraft landing except under certain exemptions.

Why it matters

These regulatory changes may significantly impact compliance requirements for organizations involved in trade or financial dealings with Iran and necessitate updates to internal policies to address new restrictions.

Action needed

Organizations must review and update compliance protocols in response to expanded trade prohibitions and prepare for restrictions on Iranian aviation effective immediately.

Relevant for
Regulatory Intelligence Lead
Processes impacted
Country Compliance
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Sep 8, 2026

Full briefing

Practical implication

Organizations must review and update compliance protocols in response to expanded trade prohibitions and prepare for restrictions on Iranian aviation effective immediately.

The Minister for the Middle East announced new legislation imposing additional sectoral sanctions on Iran to address nuclear activities that threaten international peace and security. This includes expanded trade prohibitions and restrictions on Iranian aircraft landing in the UK.

What changed: The UK Government laid 'The Iran (Sanctions) (Amendment) Regulations 2026', which amend existing sanctions regulations to impose new sectoral measures against Iran, including expanded trade prohibitions and a ban on Iranian aircraft landing except under certain exemptions.

Why it matters: These regulatory changes may significantly impact compliance requirements for organizations involved in trade or financial dealings with Iran and necessitate updates to internal policies to address new restrictions.

Practical implication: Organizations must review and update compliance protocols in response to expanded trade prohibitions and prepare for restrictions on Iranian aviation effective immediately.

View original source

  • Source: MHRA - News and communications
  • Published at source: 2026-09-08T00:00:00.000Z
  • Discovered by monitor: 2026-09-08T21:57:28.266Z

Published from the regulator source ingestion pipeline after PV impact triage.

Related updates for your role

publicTherapeutic Goods Administration (TGA) · Australia · Updated Sep 8, 2026

Updated classification rules for certain combination products

Urgency: High

Review and adjust labeling and compliance processes for affected combination products as per the new regulations.

Country ComplianceLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Labeling Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicTGA · Australia · Updated Sep 8, 2026

Clinical decision support system exemption amendments

Urgency: High

Regulatory Intelligence Leads should update their compliance checks and monitoring processes to align with the new exemption details effective from 1 November 2026.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicTGA · Australia · Updated Sep 8, 2026

New packaging rules for personal imports

Urgency: High

Review current compliance workflows and adjust processes for monitoring imports under the new packaging rules.

Signal ManagementCountry ComplianceRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicEuropean Medicines Agency · European Union · Updated Sep 8, 2026Translated From German

Agenda of the CVMP meeting 8-10 September 2026

Monitoring

Stakeholders should prepare for discussions regarding veterinary medicinal product reviews, specifically focusing on maximum residue limits and ensure all interests are declared by participants.

LabelingRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward